Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 493

1.

Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.

Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC.

Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11363-8.

2.

Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.

Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y, Li Y, Nakagawa Y, Usami S, Fujiwara M, Yamada Y, Minami T, Ueshima K, Nakao K.

Circ Res. 2010 Jun 25;106(12):1849-60. doi: 10.1161/CIRCRESAHA.109.208314.

3.
4.

Single L-type Ca(2+) channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice.

Schröder F, Klein G, Fiedler B, Bastein M, Schnasse N, Hillmer A, Ames S, Gambaryan S, Drexler H, Walter U, Lohmann SM, Wollert KC.

Cardiovasc Res. 2003 Nov 1;60(2):268-77.

6.

Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.

Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P.

Basic Res Cardiol. 2010 Sep;105(5):643-50. doi: 10.1007/s00395-010-0097-0.

PMID:
20349314
7.

Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy.

van Rooij E, Doevendans PA, de Theije CC, Babiker FA, Molkentin JD, de Windt LJ.

J Biol Chem. 2002 Dec 13;277(50):48617-26.

8.

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Wang Y, Kass DA.

Nat Med. 2005 Feb;11(2):214-22.

PMID:
15665834
9.

Intraluminal pressure is a stimulus for NFATc3 nuclear accumulation: role of calcium, endothelium-derived nitric oxide, and cGMP-dependent protein kinase.

Gonzalez Bosc LV, Wilkerson MK, Bradley KN, Eckman DM, Hill-Eubanks DC, Nelson MT.

J Biol Chem. 2004 Mar 12;279(11):10702-9.

10.

Prevention of hypertrophy by overexpression of Kv4.2 in cultured neonatal cardiomyocytes.

Zobel C, Kassiri Z, Nguyen TT, Meng Y, Backx PH.

Circulation. 2002 Oct 29;106(18):2385-91.

11.
13.

Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes.

Tongers J, Fiedler B, König D, Kempf T, Klein G, Heineke J, Kraft T, Gambaryan S, Lohmann SM, Drexler H, Wollert KC.

Cardiovasc Res. 2004 Aug 15;63(3):545-52.

14.

cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes.

Fiedler B, Feil R, Hofmann F, Willenbockel C, Drexler H, Smolenski A, Lohmann SM, Wollert KC.

J Biol Chem. 2006 Oct 27;281(43):32831-40.

15.

ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes.

Han J, Kim N, Joo H, Kim E, Earm YE.

Am J Physiol Heart Circ Physiol. 2002 Oct;283(4):H1545-54.

16.

Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.

Diedrichs H, Mei C, Frank KF, Boelck B, Schwinger RH.

J Mol Med (Berl). 2004 Oct;82(10):688-95.

PMID:
15322704
17.

T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.

Horiba M, Muto T, Ueda N, Opthof T, Miwa K, Hojo M, Lee JK, Kamiya K, Kodama I, Yasui K.

Life Sci. 2008 Mar 12;82(11-12):554-60. doi: 10.1016/j.lfs.2007.11.010.

PMID:
18275974
18.

CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.

Passier R, Zeng H, Frey N, Naya FJ, Nicol RL, McKinsey TA, Overbeek P, Richardson JA, Grant SR, Olson EN.

J Clin Invest. 2000 May;105(10):1395-406.

19.

Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.

Kato T, Sano M, Miyoshi S, Sato T, Hakuno D, Ishida H, Kinoshita-Nakazawa H, Fukuda K, Ogawa S.

Circ Res. 2000 Nov 10;87(10):937-45.

20.

Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction.

Airhart N, Yang YF, Roberts CT Jr, Silberbach M.

J Biol Chem. 2003 Oct 3;278(40):38693-8.

Items per page

Supplemental Content

Support Center